Australia markets closed

Vanda Pharmaceuticals Inc (VM4.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
5.0000-0.1000 (-1.96%)
At close: 09:59PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
177,604
192,640
254,382
268,682
248,168
Cost of revenue
13,462
14,796
24,282
25,629
23,364
Gross profit
164,142
177,844
230,100
243,053
224,804
Operating expenses
Research development
78,740
76,823
85,770
75,363
55,577
Selling general and administrative
106,864
112,883
136,485
124,047
140,510
Total operating expenses
189,333
191,796
223,771
200,888
197,565
Operating income or loss
-25,191
-13,952
6,329
42,165
27,239
Total other income/expenses net
21,338
20,291
4,971
199
4,416
Income before tax
-3,853
6,339
11,300
42,364
31,655
Income tax expense
1,036
3,830
5,025
9,212
8,318
Income from continuing operations
-4,889
2,509
6,275
33,152
23,337
Net income
-4,889
2,509
6,275
33,152
23,337
Net income available to common shareholders
-4,889
2,509
6,275
33,152
23,337
Basic EPS
0.11
-
0.11
0.60
0.43
Diluted EPS
0.11
-
0.11
0.58
0.42
Basic average shares
56,462
-
56,462
55,548
54,428
Diluted average shares
56,983
-
56,983
56,922
55,191